Ionis Pharmaceuticals Inc (IONS) — Capital Reinvestment Ratio
Ionis Pharmaceuticals Inc (IONS) has a Capital Reinvestment Ratio of 0.09x as of June 2025, meaning it reinvests 0% of its operating cash flow ($151.34 Million) in capital expenditures ($14.27 Million). See Ionis Pharmaceuticals Inc (IONS) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ionis Pharmaceuticals Inc Capital Reinvestment Ratio (2007–2021)
This chart tracks Ionis Pharmaceuticals Inc's Capital Reinvestment Ratio across 11 annual periods. Check IONS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Ionis Pharmaceuticals Inc (2007–2021)
Year-by-year Capital Reinvestment Ratio for Ionis Pharmaceuticals Inc from 2007 to 2021. For live market cap and broader valuation context, see IONS market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.58x | $30.80 Million | $17.90 Million | ▼ -49.2% |
| 2020 | 1.14x | $35.89 Million | $41.05 Million | ▲ +989.8% |
| 2019 | 0.10x | $345.72 Million | $36.28 Million | ▲ +258.4% |
| 2018 | 0.03x | $602.89 Million | $17.65 Million | ▼ -86.5% |
| 2017 | 0.22x | $174.15 Million | $37.86 Million | ▼ -60.9% |
| 2015 | 0.56x | $21.12 Million | $11.75 Million | ▼ -68.5% |
| 2014 | 1.77x | $6.29 Million | $11.10 Million | ▲ +1992.1% |
| 2013 | 0.08x | $63.49 Million | $5.36 Million | ▼ -96.9% |
| 2012 | 2.76x | $1.88 Million | $5.17 Million | ▲ +3323.7% |
| 2008 | 0.08x | $212.03 Million | $17.07 Million | ▼ -42.0% |
| 2007 | 0.14x | $36.09 Million | $5.01 Million | — |